Key Events This Week
Feb 10: Technical momentum shifts amid mixed indicator signals
Feb 12: Q3 FY26 profit surge reported, but sequential slowdown concerns emerge
Feb 12: Technical momentum shifts to mildly bearish trend
Feb 13: Technical momentum shifts to sideways amid mixed signals
Monday, 9 February 2026: Marginal Gains Amid Broad Market Rally
CARE Ratings opened the week at ₹1,649.50, registering a negligible gain of 0.01% despite the Sensex rallying 1.04% to close at 37,113.23. Trading volume was modest at 828 shares, reflecting a cautious start. The stock’s stability contrasted with the broader market optimism, indicating early hesitance among investors to push prices higher.
Tuesday, 10 February 2026: Technical Momentum Shifts Amid Mixed Signals
The stock declined sharply by 2.16% to ₹1,613.85 on increased volume of 1,570 shares, even as the Sensex advanced 0.25%. This day marked a pivotal shift in CARE Ratings’ technical momentum, moving from a mildly bearish to a mildly bullish trend according to weekly MACD and Bollinger Bands, though monthly indicators remained cautious. The divergence between short-term bullishness and longer-term caution suggested a complex technical landscape.
Wednesday, 11 February 2026: Continued Weakness Despite Market Gains
CARE Ratings extended its decline by 0.83% to ₹1,600.40 on heavy volume of 3,108 shares, while the Sensex inched up 0.13%. The stock’s technical indicators remained mixed, with weekly momentum oscillators bullish but daily moving averages turning mildly bearish. This day’s price action reflected ongoing consolidation and investor uncertainty amid conflicting signals.
Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!
- - Sustainable profitability reached
- - Post-turnaround strength
- - Comeback story unfolding
Thursday, 12 February 2026: Q3 Profit Surge Masks Sequential Slowdown; Technical Momentum Turns Mildly Bearish
CARE Ratings reported a strong profit surge for Q3 FY26, highlighting robust earnings growth. However, concerns about sequential slowdown tempered enthusiasm. The stock closed at ₹1,617.50, up 1.07% on a volume spike to 4,040 shares, while the Sensex declined 0.56%. Despite the positive earnings news, technical momentum shifted to a mildly bearish stance, with daily moving averages weakening and monthly MACD turning bearish. The mixed signals underscored a cautious market response to the earnings report.
Friday, 13 February 2026: Sideways Momentum Amid Mixed Technical Indicators
CARE Ratings ended the week at ₹1,616.60, down 0.06% on volume of 1,757 shares, as the Sensex fell 1.40%. The stock’s technical momentum shifted from mildly bearish to sideways, reflecting consolidation. Weekly MACD and KST indicators remained bullish, but monthly MACD and RSI stayed bearish. Bollinger Bands suggested mild bullishness on monthly charts, while daily moving averages remained weak. This complex interplay of signals pointed to a stock in a holding pattern, awaiting clearer directional cues.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-09 | Rs.1,649.50 | +0.01% | 37,113.23 | +1.04% |
| 2026-02-10 | Rs.1,613.85 | -2.16% | 37,207.34 | +0.25% |
| 2026-02-11 | Rs.1,600.40 | -0.83% | 37,256.72 | +0.13% |
| 2026-02-12 | Rs.1,617.50 | +1.07% | 37,049.40 | -0.56% |
| 2026-02-13 | Rs.1,616.60 | -0.06% | 36,532.48 | -1.40% |
Key Takeaways
Positive Signals: CARE Ratings demonstrated resilience with a Q3 profit surge that underpinned short-term bullish momentum, as reflected in weekly MACD and Bollinger Bands. The stock’s long-term performance remains robust, with 5-year returns exceeding 226%, significantly outpacing the Sensex.
Cautionary Notes: Despite short-term strength, the stock faced a technical shift to mildly bearish and sideways momentum by week’s end. Monthly MACD and RSI indicators suggest longer-term caution, while daily moving averages indicate weakening momentum. The stock underperformed the Sensex by 1.45% over the week, highlighting relative weakness amid broader market declines.
Volume Trends: Volume spikes on days of technical shifts and earnings announcements suggest active trading interest, but mixed On-Balance Volume readings imply uncertainty in accumulation versus distribution dynamics.
Is CARE Ratings Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Conclusion
CARE Ratings Ltd’s week was characterised by a nuanced technical landscape and fundamental developments that together shaped a cautious market stance. The Q3 profit surge provided a positive catalyst, yet mixed technical signals and a shift to sideways momentum tempered enthusiasm. The stock’s underperformance relative to the Sensex and weakening daily moving averages suggest that investors should remain vigilant amid ongoing consolidation.
Long-term investors may find reassurance in the company’s strong historical returns and recent upgrade to a Hold rating, while short-term traders should closely monitor key technical levels for signs of breakout or breakdown. The interplay of bullish weekly indicators with bearish monthly signals highlights the importance of timeframe perspective in assessing CARE Ratings’ near-term trajectory within the capital markets sector.
Unlock special upgrade rates for a limited period. Start Saving Now →
